Ms. Gina M. Patterson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 S Elk St, Sandusky, MI 48471 Phone: 810-648-2265 Fax: 810-648-5968 |
Aram J Makkinejad Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39 Kristian St, Sandusky, MI 48471 Phone: 810-648-4668 |
Mr. Gerald A. Smith, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 S Elk St, Sandusky, MI 48471 Phone: 810-648-2265 Fax: 810-648-5968 |
Dr. Kevin Dieckmann, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 655 W Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-4247 |
Jordin Taylor Verbeke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 S Elk St, Sandusky, MI 48471 Phone: 810-648-2265 |
Hossam Hawari Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 545 W Sanilac Rd, Pharmacy, Sandusky, MI 48471 Phone: 810-648-5136 |
Shravana Lakshmi Nayani Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 655 W Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-4247 |
News Archive
A new study, published online in the journal Heart in March 2020, reports that with hot water, it seems to be a case of washing away health problems – literally. As a result, the more a person uses hot tubs, the better in terms of cardiovascular health. In other words, soaking in hot water daily improves heart health more than having a hot tub once or twice a day.
Feeding pregnant female mice a diet high in fat derived from common corn oil resulted in genetic changes that substantially increased breast cancer susceptibility in three generations of female offspring, reports a team of researchers led by scientists at Georgetown Lombardi Comprehensive Cancer Center.
As millions of Americans prepare to enjoy the great outdoors Memorial Day weekend, the National Council on Skin Cancer Prevention reminds everyone to practice sun-safe behaviors – pack those wide-brimmed hats in the suitcase. The incidence of melanoma (the most fatal of skin cancers) continues to rise significantly, at a rate faster than any of the seven most common cancers.
Tarsa Therapeutics, Inc. today announced completion of its global Phase III ORACAL trial testing the company's once-daily oral recombinant calcitonin for the treatment of postmenopausal osteoporosis. Results from the ORACAL trial are expected in early spring. In addition, Tarsa announced initiation of a new Phase II study of its oral calcitonin for the prevention of postmenopausal osteoporosis.
A Japanese research team has become the first in the world to discover that 2-aminobutyric acid (2-AB) is closely involved in the metabolic regulation of the antioxidant glutathione, and that it can effectively raise levels of glutathione in the body when ingested. The findings were published in the online version of Scientific Reports on November 9.
› Verified 9 days ago